Global Renal Diseases Drug Market Growth (Status and Outlook) 2025-2031

September 2025 | 110 pages | ID: G44A2EEA666CEN
LP Information

Abstracts

According to this study, the global Renal Diseases Drug market size will reach US$ million by 2031.

Kidney disease commonly referred to as kidney disease or kidney disease, mainly manifested as abnormal urine volume, urination abnormalities, lumbago.Kidney disease drugs include blood pressure drugs, anti-hyperlipidemia drugs, erythropoietics (ESA), diuretics and so on.

United States market for Renal Diseases Drug is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Renal Diseases Drug is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Renal Diseases Drug is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Renal Diseases Drug players cover Pfizer, Amgen, Roche, GlaxoSmithKline (GSK), Allergan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Renal Diseases Drug Industry Forecast” looks at past sales and reviews total world Renal Diseases Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Renal Diseases Drug sales for 2025 through 2031. With Renal Diseases Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Renal Diseases Drug industry.

This Insight Report provides a comprehensive analysis of the global Renal Diseases Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Renal Diseases Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Renal Diseases Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Renal Diseases Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Renal Diseases Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Renal Diseases Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Chronic Kidney Disease (CKD) Drugs
• End-Stage Kidney Disease (ESRD) Drugs

Segmentation by Application:

• Hospitals
• Specialty Clinics
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Amgen
• Roche
• GlaxoSmithKline (GSK)
• Allergan
• AbbVie
• Kissei Pharmaceutical
• AstraZeneca
• FibroGen
• Sanofi
• Teva Pharmaceutical Industries
• Johnson & Johnson
• Keryx Biopharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Renal Diseases Drug Market Size (2020-2031)
  2.1.2 Renal Diseases Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Renal Diseases Drug by Country/Region (2020, 2024 & 2031)
2.2 Renal Diseases Drug Segment by Type
  2.2.1 Chronic Kidney Disease (CKD) Drugs
  2.2.2 End-Stage Kidney Disease (ESRD) Drugs
2.3 Renal Diseases Drug Market Size by Type
  2.3.1 Renal Diseases Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Renal Diseases Drug Market Size Market Share by Type (2020-2025)
2.4 Renal Diseases Drug Segment by Application
  2.4.1 Hospitals
  2.4.2 Specialty Clinics
  2.4.3 Other
2.5 Renal Diseases Drug Market Size by Application
  2.5.1 Renal Diseases Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Renal Diseases Drug Market Size Market Share by Application (2020-2025)

3 RENAL DISEASES DRUG MARKET SIZE BY PLAYER

3.1 Renal Diseases Drug Market Size Market Share by Player
  3.1.1 Global Renal Diseases Drug Revenue by Player (2020-2025)
  3.1.2 Global Renal Diseases Drug Revenue Market Share by Player (2020-2025)
3.2 Global Renal Diseases Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RENAL DISEASES DRUG BY REGION

4.1 Renal Diseases Drug Market Size by Region (2020-2025)
4.2 Global Renal Diseases Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Renal Diseases Drug Market Size Growth (2020-2025)
4.4 APAC Renal Diseases Drug Market Size Growth (2020-2025)
4.5 Europe Renal Diseases Drug Market Size Growth (2020-2025)
4.6 Middle East & Africa Renal Diseases Drug Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Renal Diseases Drug Market Size by Country (2020-2025)
5.2 Americas Renal Diseases Drug Market Size by Type (2020-2025)
5.3 Americas Renal Diseases Drug Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Renal Diseases Drug Market Size by Region (2020-2025)
6.2 APAC Renal Diseases Drug Market Size by Type (2020-2025)
6.3 APAC Renal Diseases Drug Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Renal Diseases Drug Market Size by Country (2020-2025)
7.2 Europe Renal Diseases Drug Market Size by Type (2020-2025)
7.3 Europe Renal Diseases Drug Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Renal Diseases Drug by Region (2020-2025)
8.2 Middle East & Africa Renal Diseases Drug Market Size by Type (2020-2025)
8.3 Middle East & Africa Renal Diseases Drug Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RENAL DISEASES DRUG MARKET FORECAST

10.1 Global Renal Diseases Drug Forecast by Region (2026-2031)
  10.1.1 Global Renal Diseases Drug Forecast by Region (2026-2031)
  10.1.2 Americas Renal Diseases Drug Forecast
  10.1.3 APAC Renal Diseases Drug Forecast
  10.1.4 Europe Renal Diseases Drug Forecast
  10.1.5 Middle East & Africa Renal Diseases Drug Forecast
10.2 Americas Renal Diseases Drug Forecast by Country (2026-2031)
  10.2.1 United States Market Renal Diseases Drug Forecast
  10.2.2 Canada Market Renal Diseases Drug Forecast
  10.2.3 Mexico Market Renal Diseases Drug Forecast
  10.2.4 Brazil Market Renal Diseases Drug Forecast
10.3 APAC Renal Diseases Drug Forecast by Region (2026-2031)
  10.3.1 China Renal Diseases Drug Market Forecast
  10.3.2 Japan Market Renal Diseases Drug Forecast
  10.3.3 Korea Market Renal Diseases Drug Forecast
  10.3.4 Southeast Asia Market Renal Diseases Drug Forecast
  10.3.5 India Market Renal Diseases Drug Forecast
  10.3.6 Australia Market Renal Diseases Drug Forecast
10.4 Europe Renal Diseases Drug Forecast by Country (2026-2031)
  10.4.1 Germany Market Renal Diseases Drug Forecast
  10.4.2 France Market Renal Diseases Drug Forecast
  10.4.3 UK Market Renal Diseases Drug Forecast
  10.4.4 Italy Market Renal Diseases Drug Forecast
  10.4.5 Russia Market Renal Diseases Drug Forecast
10.5 Middle East & Africa Renal Diseases Drug Forecast by Region (2026-2031)
  10.5.1 Egypt Market Renal Diseases Drug Forecast
  10.5.2 South Africa Market Renal Diseases Drug Forecast
  10.5.3 Israel Market Renal Diseases Drug Forecast
  10.5.4 Turkey Market Renal Diseases Drug Forecast
10.6 Global Renal Diseases Drug Forecast by Type (2026-2031)
10.7 Global Renal Diseases Drug Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Renal Diseases Drug Forecast

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Renal Diseases Drug Product Offered
  11.1.3 Pfizer Renal Diseases Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Amgen
  11.2.1 Amgen Company Information
  11.2.2 Amgen Renal Diseases Drug Product Offered
  11.2.3 Amgen Renal Diseases Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Amgen Main Business Overview
  11.2.5 Amgen Latest Developments
11.3 Roche
  11.3.1 Roche Company Information
  11.3.2 Roche Renal Diseases Drug Product Offered
  11.3.3 Roche Renal Diseases Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Roche Main Business Overview
  11.3.5 Roche Latest Developments
11.4 GlaxoSmithKline (GSK)
  11.4.1 GlaxoSmithKline (GSK) Company Information
  11.4.2 GlaxoSmithKline (GSK) Renal Diseases Drug Product Offered
  11.4.3 GlaxoSmithKline (GSK) Renal Diseases Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 GlaxoSmithKline (GSK) Main Business Overview
  11.4.5 GlaxoSmithKline (GSK) Latest Developments
11.5 Allergan
  11.5.1 Allergan Company Information
  11.5.2 Allergan Renal Diseases Drug Product Offered
  11.5.3 Allergan Renal Diseases Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Allergan Main Business Overview
  11.5.5 Allergan Latest Developments
11.6 AbbVie
  11.6.1 AbbVie Company Information
  11.6.2 AbbVie Renal Diseases Drug Product Offered
  11.6.3 AbbVie Renal Diseases Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 AbbVie Main Business Overview
  11.6.5 AbbVie Latest Developments
11.7 Kissei Pharmaceutical
  11.7.1 Kissei Pharmaceutical Company Information
  11.7.2 Kissei Pharmaceutical Renal Diseases Drug Product Offered
  11.7.3 Kissei Pharmaceutical Renal Diseases Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Kissei Pharmaceutical Main Business Overview
  11.7.5 Kissei Pharmaceutical Latest Developments
11.8 AstraZeneca
  11.8.1 AstraZeneca Company Information
  11.8.2 AstraZeneca Renal Diseases Drug Product Offered
  11.8.3 AstraZeneca Renal Diseases Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 AstraZeneca Main Business Overview
  11.8.5 AstraZeneca Latest Developments
11.9 FibroGen
  11.9.1 FibroGen Company Information
  11.9.2 FibroGen Renal Diseases Drug Product Offered
  11.9.3 FibroGen Renal Diseases Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 FibroGen Main Business Overview
  11.9.5 FibroGen Latest Developments
11.10 Sanofi
  11.10.1 Sanofi Company Information
  11.10.2 Sanofi Renal Diseases Drug Product Offered
  11.10.3 Sanofi Renal Diseases Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Sanofi Main Business Overview
  11.10.5 Sanofi Latest Developments
11.11 Teva Pharmaceutical Industries
  11.11.1 Teva Pharmaceutical Industries Company Information
  11.11.2 Teva Pharmaceutical Industries Renal Diseases Drug Product Offered
  11.11.3 Teva Pharmaceutical Industries Renal Diseases Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Teva Pharmaceutical Industries Main Business Overview
  11.11.5 Teva Pharmaceutical Industries Latest Developments
11.12 Johnson & Johnson
  11.12.1 Johnson & Johnson Company Information
  11.12.2 Johnson & Johnson Renal Diseases Drug Product Offered
  11.12.3 Johnson & Johnson Renal Diseases Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Johnson & Johnson Main Business Overview
  11.12.5 Johnson & Johnson Latest Developments
11.13 Keryx Biopharmaceuticals
  11.13.1 Keryx Biopharmaceuticals Company Information
  11.13.2 Keryx Biopharmaceuticals Renal Diseases Drug Product Offered
  11.13.3 Keryx Biopharmaceuticals Renal Diseases Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Keryx Biopharmaceuticals Main Business Overview
  11.13.5 Keryx Biopharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Renal Diseases Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Renal Diseases Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Chronic Kidney Disease (CKD) Drugs
Table 4. Major Players of End-Stage Kidney Disease (ESRD) Drugs
Table 5. Renal Diseases Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Renal Diseases Drug Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Renal Diseases Drug Market Size Market Share by Type (2020-2025)
Table 8. Renal Diseases Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Renal Diseases Drug Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Renal Diseases Drug Market Size Market Share by Application (2020-2025)
Table 11. Global Renal Diseases Drug Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Renal Diseases Drug Revenue Market Share by Player (2020-2025)
Table 13. Renal Diseases Drug Key Players Head office and Products Offered
Table 14. Renal Diseases Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Renal Diseases Drug Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Renal Diseases Drug Market Size Market Share by Region (2020-2025)
Table 19. Global Renal Diseases Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Renal Diseases Drug Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Renal Diseases Drug Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Renal Diseases Drug Market Size Market Share by Country (2020-2025)
Table 23. Americas Renal Diseases Drug Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Renal Diseases Drug Market Size Market Share by Type (2020-2025)
Table 25. Americas Renal Diseases Drug Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Renal Diseases Drug Market Size Market Share by Application (2020-2025)
Table 27. APAC Renal Diseases Drug Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Renal Diseases Drug Market Size Market Share by Region (2020-2025)
Table 29. APAC Renal Diseases Drug Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Renal Diseases Drug Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Renal Diseases Drug Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Renal Diseases Drug Market Size Market Share by Country (2020-2025)
Table 33. Europe Renal Diseases Drug Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Renal Diseases Drug Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Renal Diseases Drug Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Renal Diseases Drug Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Renal Diseases Drug Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Renal Diseases Drug
Table 39. Key Market Challenges & Risks of Renal Diseases Drug
Table 40. Key Industry Trends of Renal Diseases Drug
Table 41. Global Renal Diseases Drug Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Renal Diseases Drug Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Renal Diseases Drug Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Renal Diseases Drug Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Pfizer Details, Company Type, Renal Diseases Drug Area Served and Its Competitors
Table 46. Pfizer Renal Diseases Drug Product Offered
Table 47. Pfizer Renal Diseases Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Pfizer Main Business
Table 49. Pfizer Latest Developments
Table 50. Amgen Details, Company Type, Renal Diseases Drug Area Served and Its Competitors
Table 51. Amgen Renal Diseases Drug Product Offered
Table 52. Amgen Renal Diseases Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Amgen Main Business
Table 54. Amgen Latest Developments
Table 55. Roche Details, Company Type, Renal Diseases Drug Area Served and Its Competitors
Table 56. Roche Renal Diseases Drug Product Offered
Table 57. Roche Renal Diseases Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Roche Main Business
Table 59. Roche Latest Developments
Table 60. GlaxoSmithKline (GSK) Details, Company Type, Renal Diseases Drug Area Served and Its Competitors
Table 61. GlaxoSmithKline (GSK) Renal Diseases Drug Product Offered
Table 62. GlaxoSmithKline (GSK) Renal Diseases Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. GlaxoSmithKline (GSK) Main Business
Table 64. GlaxoSmithKline (GSK) Latest Developments
Table 65. Allergan Details, Company Type, Renal Diseases Drug Area Served and Its Competitors
Table 66. Allergan Renal Diseases Drug Product Offered
Table 67. Allergan Renal Diseases Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Allergan Main Business
Table 69. Allergan Latest Developments
Table 70. AbbVie Details, Company Type, Renal Diseases Drug Area Served and Its Competitors
Table 71. AbbVie Renal Diseases Drug Product Offered
Table 72. AbbVie Renal Diseases Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. AbbVie Main Business
Table 74. AbbVie Latest Developments
Table 75. Kissei Pharmaceutical Details, Company Type, Renal Diseases Drug Area Served and Its Competitors
Table 76. Kissei Pharmaceutical Renal Diseases Drug Product Offered
Table 77. Kissei Pharmaceutical Renal Diseases Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Kissei Pharmaceutical Main Business
Table 79. Kissei Pharmaceutical Latest Developments
Table 80. AstraZeneca Details, Company Type, Renal Diseases Drug Area Served and Its Competitors
Table 81. AstraZeneca Renal Diseases Drug Product Offered
Table 82. AstraZeneca Renal Diseases Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. AstraZeneca Main Business
Table 84. AstraZeneca Latest Developments
Table 85. FibroGen Details, Company Type, Renal Diseases Drug Area Served and Its Competitors
Table 86. FibroGen Renal Diseases Drug Product Offered
Table 87. FibroGen Renal Diseases Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. FibroGen Main Business
Table 89. FibroGen Latest Developments
Table 90. Sanofi Details, Company Type, Renal Diseases Drug Area Served and Its Competitors
Table 91. Sanofi Renal Diseases Drug Product Offered
Table 92. Sanofi Renal Diseases Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Sanofi Main Business
Table 94. Sanofi Latest Developments
Table 95. Teva Pharmaceutical Industries Details, Company Type, Renal Diseases Drug Area Served and Its Competitors
Table 96. Teva Pharmaceutical Industries Renal Diseases Drug Product Offered
Table 97. Teva Pharmaceutical Industries Renal Diseases Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Teva Pharmaceutical Industries Main Business
Table 99. Teva Pharmaceutical Industries Latest Developments
Table 100. Johnson & Johnson Details, Company Type, Renal Diseases Drug Area Served and Its Competitors
Table 101. Johnson & Johnson Renal Diseases Drug Product Offered
Table 102. Johnson & Johnson Renal Diseases Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Johnson & Johnson Main Business
Table 104. Johnson & Johnson Latest Developments
Table 105. Keryx Biopharmaceuticals Details, Company Type, Renal Diseases Drug Area Served and Its Competitors
Table 106. Keryx Biopharmaceuticals Renal Diseases Drug Product Offered
Table 107. Keryx Biopharmaceuticals Renal Diseases Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Keryx Biopharmaceuticals Main Business
Table 109. Keryx Biopharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Renal Diseases Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Renal Diseases Drug Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Renal Diseases Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Renal Diseases Drug Sales Market Share by Country/Region (2024)
Figure 8. Renal Diseases Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Renal Diseases Drug Market Size Market Share by Type in 2024
Figure 10. Renal Diseases Drug in Hospitals
Figure 11. Global Renal Diseases Drug Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Renal Diseases Drug in Specialty Clinics
Figure 13. Global Renal Diseases Drug Market: Specialty Clinics (2020-2025) & ($ millions)
Figure 14. Renal Diseases Drug in Other
Figure 15. Global Renal Diseases Drug Market: Other (2020-2025) & ($ millions)
Figure 16. Global Renal Diseases Drug Market Size Market Share by Application in 2024
Figure 17. Global Renal Diseases Drug Revenue Market Share by Player in 2024
Figure 18. Global Renal Diseases Drug Market Size Market Share by Region (2020-2025)
Figure 19. Americas Renal Diseases Drug Market Size 2020-2025 ($ millions)
Figure 20. APAC Renal Diseases Drug Market Size 2020-2025 ($ millions)
Figure 21. Europe Renal Diseases Drug Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Renal Diseases Drug Market Size 2020-2025 ($ millions)
Figure 23. Americas Renal Diseases Drug Value Market Share by Country in 2024
Figure 24. United States Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Renal Diseases Drug Market Size Market Share by Region in 2024
Figure 29. APAC Renal Diseases Drug Market Size Market Share by Type (2020-2025)
Figure 30. APAC Renal Diseases Drug Market Size Market Share by Application (2020-2025)
Figure 31. China Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 35. India Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Renal Diseases Drug Market Size Market Share by Country in 2024
Figure 38. Europe Renal Diseases Drug Market Size Market Share by Type (2020-2025)
Figure 39. Europe Renal Diseases Drug Market Size Market Share by Application (2020-2025)
Figure 40. Germany Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 41. France Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Renal Diseases Drug Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Renal Diseases Drug Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Renal Diseases Drug Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Renal Diseases Drug Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 54. APAC Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 55. Europe Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 57. United States Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 58. Canada Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 59. Mexico Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 60. Brazil Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 61. China Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 62. Japan Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 63. Korea Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 65. India Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 66. Australia Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 67. Germany Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 68. France Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 69. UK Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 70. Italy Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 71. Russia Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 72. Egypt Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 73. South Africa Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 74. Israel Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 75. Turkey Renal Diseases Drug Market Size 2026-2031 ($ millions)
Figure 76. Global Renal Diseases Drug Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Renal Diseases Drug Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Renal Diseases Drug Market Size 2026-2031 ($ millions)